Literature DB >> 33389719

Secondary analysis of YFAS 2.0 symptom counts, impairment/distress, and food addiction severity in adults with overweight/obesity.

Ann Koehler1, Trina Aguirre2, Erica Schulte3,4, Rebecca Bowman5,6, Leeza Struwe7.   

Abstract

PURPOSE: Understanding the complexities of obesity is important for developing effective interventions. Evidence is growing that addictive-like tendencies toward foods may contribute to obesity in some individuals. The Yale Food Addiction Scale (YFAS, YFAS 2.0) was developed to identify individuals with addictive-like eating behaviors. Diagnosing food addiction (FA) requires meeting a symptom threshold plus clinically significant impairment/distress (self-perceived), but the utility of the impairment/distress criteria remains controversial. This secondary analysis compared individuals who did not meet the FA symptom criteria, met the symptom, but not the impairment/distress criteria, and met both criteria.
METHODS: This secondary analysis of data from a randomized controlled pilot study involving 83 adults with overweight/obesity used descriptive statistics and Univariate ANOVAS to compare YFAS 2.0 and Weight and Lifestyle Inventory responses among the groups.
RESULTS: Twenty-eight individuals did not meet the FA symptom criteria, 20 met the symptom, but not the impairment/distress criteria, and 35 met both criteria. Of the latter, 80.0% had severe, 8.6% had moderate, and 11.4% had mild FA. Age at onset of overweight was lower with severe than with mild FA (p = 0.023).
CONCLUSIONS: The YFAS 2.0 identified a distinct group with severe FA and a group who met the FA symptom threshold, but not the impairment/distress criteria. Few participants perceived impairment/distress unless they endorsed ≥ 6 symptoms. Adding clinical interviews may aid in assessing impairment/distress and addictive-like eating behaviors, particularly in those meeting the FA symptom, but not the impairment/distress criteria. Better characterization of these groups may help targeting obesity interventions. TRIAL REGISTRATION NUMBER: NCT03431831, 1/30/2018. LEVEL OF EVIDENCE: Level III, case-control analytic study.

Entities:  

Keywords:  Eating behavior; Food addiction; Obesity; Yale Food Addiction Scale 2.0

Year:  2021        PMID: 33389719     DOI: 10.1007/s40519-020-01077-1

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  5 in total

1.  Development of the Yale Food Addiction Scale Version 2.0.

Authors:  Ashley N Gearhardt; William R Corbin; Kelly D Brownell
Journal:  Psychol Addict Behav       Date:  2016-02

2.  Preliminary validation of the Yale Food Addiction Scale.

Authors:  Ashley N Gearhardt; William R Corbin; Kelly D Brownell
Journal:  Appetite       Date:  2008-12-11       Impact factor: 3.868

Review 3.  Obesity: definition, comorbidities, causes, and burden.

Authors:  Caroline M Apovian
Journal:  Am J Manag Care       Date:  2016-06       Impact factor: 2.229

4.  Establishing a food addiction diagnosis using the Yale Food Addiction Scale: A closer look at the clinically significant distress/functional impairment criterion.

Authors:  Anne-Sophie Ouellette; Christopher Rodrigue; Simone Lemieux; André Tchernof; Laurent Biertho; Catherine Bégin
Journal:  Appetite       Date:  2018-06-30       Impact factor: 3.868

5.  Which foods may be addictive? The roles of processing, fat content, and glycemic load.

Authors:  Erica M Schulte; Nicole M Avena; Ashley N Gearhardt
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

  5 in total
  2 in total

1.  Examining impairment and distress from food addiction across demographic and weight groups.

Authors:  Meagan M Carr; Jessica L Lawson; Ashley A Wiedemann; Rachel D Barnes
Journal:  Eat Behav       Date:  2021-10-09

2.  Childhood sexual abuse and food addiction severity in a clinical sample of individuals with overweight or obesity.

Authors:  Maxime Legendre; Stéphane Sabourin; Catherine Bégin
Journal:  Eat Weight Disord       Date:  2022-08-22       Impact factor: 3.008

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.